The CeO2 nanoparticles are very interesting to be studied as biomedical materials 
INTRODUCTION
Metal oxide nanoparticles have been widely used in various fields of application, i.e.: electronic, energy, environmental remediation and medical. Nowadays, various metal oxide nanoparticles are explored as antioxidant, such as: TiO2 (Bajic et al., 2017; Santhoshkumar et al., 2014) , ZnO Suresh et al., 2015; Madan et al., 2016) CuO (Das et al., 2013; Purkayastha et al., 2014) , NiO (Madhu et al., 2013; Saikia et al., 2010) , SnO2 (Vidhu and Philip, 2015) , MgO (Sushma et al., 2016) and CeO2 (Kim and Chung, 2016; Dunnick et al., 2015; Soren et al., 2015) . Antioxidant is a substance that could delay or prevent oxidation process caused by free radicals.
Antioxidant in a form of nanoparticles (nanoantioxidant) is a new strategy to prevent free radicals caused diseases. In regard to their small size, the nanoparticles antioxidant could interact with biomolecules on the cell surfaces as well as inside the cells. The use of nanoparticles antioxidant was proven to be effective in the prevention of cell damage caused by free radical (Sandhir et al., 2015; Liu et al., 2008) . CeO2 nanoparticles are metal oxide nanoparticles, which widely used for medical applications such as radioprotector in the radiotherapy and catalyst for their pharmacological potentials. The combination of strong absorption property to UV light and the interaction of CeO2 nanoparticles with free radical showed that CeO2 is a more effective sunscreen material than TiO2 and ZnO that commonly used in cosmetic products. Moreover, the antioxidant properties of CeO2 nanoparticles also provide good protection against free radical formed by UV exposure (Zholobak et al., 2014; Nurhasanah et al., 2014) . The ability of CeO2 nanoparticles to exhibit antioxidant property comes from oxygen vacancy on it surfaces that proceeds redox reaction. Many researches showed that antioxidant properties of CeO2 were influenced by it shape, size, valence state and synthesis method (Leung et al., 2015; Dunnick et al., 2015; Soren et al., 2015) .
CeO2 nanoparticles also showed high radioprotective activity and health maintenance toward animal living cells (Colon et al., 2009) . The CeO2 nanoparticles have been proven could protect healthy tissue around cancer tissue in radiotherapy treatment (Wason and Zao, 2013) . However, as found in other synthetic radioprotector materials, the use of CeO2 is also limited by its toxic concentration limit (dose). The dose will be depended on the radioprotector material structure and the radiated tissue.
In this research, the antioxidant properties and dose enhancement factor of CeO2 nanoparticles were studied to explore the protection ability of CeO2 toward radiation from X-rays Linac 6 MV. CeO2 nanoparticles were synthesized by precipitation method that can be applied at industrial scale. Calcination temperature was varied to study its effect on the antioxidant activity and dose enhancement factor of CeO2 nanoparticles. The radioprotection ability of CeO2 nanoparticles was evaluated by using X-rays radiated Escherichia coli.
METHOD
CeO2 nanoparticles were synthesized by precipitation of cerium (III) nitrate hexahydrate (99%, Sigma Aldrich), and followed by calcination process at 300-700 o C for 2 hours. The details of the synthesis procedure have been reported previously (Nurhasanah et al., 2014) . Nanoparticles structure was analyzed using X-rays diffractometer (PW 1710). The nanoparticles antioxidant activity was tested using DPPH method. Dose enhancement factor (DEF) was determined from the measurement of X-rays Linac 6 MV at a dose rate of 200 cGy/minute. Protective effect of CeO2 nanoparticles with various concentrations (20 to 100 µg) was tested to X-rays radiated Escherichia coli (E. coli) with a dose of 2 Gy.
RESULTS AND DISCUSSION
The X-ray diffraction pattern of the products synthesized at various calcination temperatures is shown in Figure 1 . The diffraction pattern showed crystal plane of (111), (200), (220), (311), (222), (400), (331), (420) and (422) that characteristic to CeO2 fluorite cubic structure. The sharp and narrow diffraction peaks appear at calcination temperature of 600°C and 700°C, whereas at 300-500°C the peaks have no significant changes with the increasing calcination temperature. The wide diffraction peak indicated that CeO2 is composed of nano-sized crystallites. The crystallites size of CeO2 nanoparticles was determined using the Scherrer formula expressed by equation (1) for the crystal plane of (111) 
Where k is a constant of 0.89,  is the full width at half maximum (FWHM) diffraction peak and  is diffraction angle. Figure 2 shows the crystallites size of CeO2 nanoparticles at various calcination temperatures. The crystallites size significantly increased at 600 o C and 700 o C from 9.82 to 17.76 nm. As seen in Figure 1 , the peaks for crystal plane of (111) became narrower as calcination temperature increase from 500 to 600 o C and 700 o C. The calcination temperature at 300-500 o C did not give significant effect on the crystallite size due to insignificant difference of the FWHM. The precipitates still have a high porosity. The calcination at temperature 300 to 500 o C has a dominant role in the formation of pores interconnect, so that the crystallite size is almost unchanged. After the interconnect pores are formed, the calcination at temperature > 500 o C contributes to the crystallite growth. Antioxidants are compounds that can prevent oxidation by free radicals. Antioxidants react with free radiacals so they become unreactive, stabilizing the free radicals by pairing the electrons and prevent chain reactions. The antioxidant activity of the CeO2 nanoparticles was tested by DPPH method for its simplicity and high accuracy. The antioxidant activity is expressed as the value of IC50 which reflects the amount of antioxidant compounds required to reduce 50% of DPPH absorbance. Figure 3 shows the calculated IC50value of CeO2 nanoparticles obtained at various temperatures. The IC50 values were ranged from 4.38 to 4.73 mg/mL. The smallest IC50 value indicates the highest antioxidant activity. The data showed that calcination at 500 o C produced CeO2 nanoparticles with the highest antioxidant activity. The antioxidant activity of CeO2 nanoparticles come from Ce 3+ valency state and oxygen vacancy. Electrons were transfered from CeO2 to nonpaired electron of nitrogen in DPPH (Zholobak et al., 2014; Dunnick et al., 2015) . Furthermore, antioxidant activity of CeO2nanoparticles may also be affected by the size, shape and synthesis method. The antioxidant activity of CeO2 nanoparticles obtained in this research is higher than those synthesized using solvothermal method that only prevent 30% of DPPH free radicals (Soren et al., 2015) . It is also higher than ZnO nanoparticles that have IC50 value about 8 mg/mL Suresh et al., 2015; Madan et al., 2016) .
Antioxidant compounds are used in cancer therapy to protect normal cells from radiation effects. The interaction of radiation with the cells will produce free radical that derived from radiolysis reactions. Then the free radicals will react with cancer cells and also with normal cells around the cancer. To minimize the radiation effect on the normal cells, radioprotector compounds are required. They should be able to protect normal cells from radiation damage. A compound has potential as radioprotector if it could absorb (decrease) radiation dose or has dose enhancement factor (DEF) less than one. Figure 4 shows DEF value of CeO2 nanoparticles that calcined at various temperatures for X-rays LINAC 6 MV at a dose of 2 Gy. The DEF of CeO2 nanoparticles is ranging from 0.9918 to 0.9934, which is smaller than one. This indicates the potential of CeO2 nanoparticles as a radioprotector. The CeO2 nanoparticles synthesized at 500 o C possess the lowest DEF value. This result is consistent with the antioxidant activity as shown in Figure 3 . The potential of CeO2 nanoparticles as a radioprotector was further tested using E. coli bacteria that radiated with X-rays Linac 6 MV at a dose of 2 Gy. The CeO2 nanoparticles were added to E. coli media with various concentrations to determine the effectiveness of CeO2 nanoparticles as radioprotector. The ability of nanoparticles to protect E. coli from damage that caused by radiation is indicated by the percentage of E. coli survival as shown in Figure 5 .
The addition of CeO2 nanoparticles to radiated E. coli has improved its survival percentage. Treatments of radiated E. coli with 20; 40 and 60 µg of CeO2 nanoparticles have increased the survival percentage as 24.8, 14.8 and 12.28%, which are higher than the untreated one. The data showed that addition of 20 µg CeO2 nanoparticles exhibited the highest survival percentage of E. coli due to their ability in reducing the cells damage. The survival percentage of In general, there are three mechanisms that could cause the death of bacteria; (i) incident or primary radiation, (ii) interaction between E. coli and secondary electrons, and (iii) interaction of E. coli with free radicals. Secondary electrons are produced from the interactions of incident radiation with CeO2 nanoparticles. Meanwhile, the free radicals are generated from the interactions between H2O and O2 molecules with incident radiation and interactions of H2O and O2 with secondary electrons (Colon et al., 2009 Based on this research, the radioprotective activity of CeO2 nanoparticles can be increased by reducing the concentration of CeO2 nanoparticles.
CONCLUSION
CeO2 nanoparticles synthesized using precipitation method at calcination temperature of 300-700 o C showed antioxidant activity with IC50 of 4.38 to 4.73 mg/mL. Dose Enhancement Factor of CeO2 nanoparticles were less than one, ranging from 0.9918-0.9934. The Addition of CeO2 nanoparticles with concentration of 20µg reduced the damage cells induced by X-ray radiation and improved E. coli survival by 24.8%. CeO2 nanoparticles can be recommended as X-rays LINAC 6 MV radioprotector. Further research is needed to obtain the optimum radioprotective activity of CeO2 nanoparticles.
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